The Week that Was: Indian Startup News Overview (19th May - 25th May)
- Indian startups across multiple sectors secured funding rounds ranging from Pre-Seed to Series C, showing strong growth momentum.
- Nobel Hygiene raised Rs 170 crore in a Pre-IPO round to expand its presence in the adult diaper market ahead of its IPO.
- CureBay secured $21 million in Series B funding to expand rural healthcare services in underserved Indian states.
- Biostate AI raised $12 million in Series A to develop AI-driven RNA sequencing technology for precision medicine.
- Fleetx.io and Stable Money raised significant funds over Rs 100 crore in Series C and Rs 173 crore in Series B.
The Indian startup ecosystem has set a new record by bagging another round of funding in a few sectors like Climate tech, Travel, Aviation Tech, Retail Apparel and Fashion, Chemical Manufacturing & Digital Entertainment marks another win for the startupreneurs by raising funds and updating the growth probability and standardizing the products and services. The week went by successfully witnessing funds in every stage of funding from Pre-Seed, Pre-series, Seed, Series C, & others.
Funding News: Biostate AI Secures $12 Million in Series A Funding Led by Accel
Startup: Biostate AI
Founder: Ashwin Gopinath and David Zhang
About us: Biostate AI's mission is to develop generative AI that can benefit all of human health. We observe that biological beings are dynamic systems, with each individual slightly different today vs. yesterday or tomorrow.
Founded Year: 2023
Office: Houston
Funding Round: Series A
Investors: Accel
Biostate AI, a startup focused on AI and RNA sequencing, said that it has raised $12 million in a Series A round led by Accel. The investment round also saw Gaingels, Mana Ventures, InfoEdge Ventures, and repeat investors Matter Venture Partners, Vision Plus Capital, and Catapult Ventures. The new capital will go toward increasing access to precision medicine integration, starting with RNA sequencing (RNAseq) services for molecular research in the US.
The company is now focused on bringing RNA sequencing within everyone's reach and developing predictive models to support clinical decision-making. Houston, Texas-based Biostate AI is striving to overcome challenges in RNA sequencing by combining biochemical approaches with generative AI.
Website: https://www.biostate.ai/

